Dr. Dana Al-Sulaiman is a postdoctorate research fellow in the Department of Chemical Engineering at MIT. Her research has focused on developing hydrogel-based optical and electrical platforms for the detection of an emerging class of cancer biomarkers called cell-free nucleic acids. These platforms aim to enable minimally invasive and earlier diagnosis of cancer at the point of care.

Currently, Dana’s research combines microfluidics, microfabrication techniques, and hydrogels to develop biomarker detection platforms that can inform clinical decision making and provide more personalized and informed therapeutics for cancer patients. Dana received her MEng in Biomedical Engineering and her PhD in Bioengineering from Imperial College London, supported by the President’s PhD Scholarship. She is also the recipient of the 2019 Institute of Engineering and Technology (IET) Healthcare technologies award (William James category).

Contact: danasul@mit.edu